ResMed Inc. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was USD 1,033.74 million compared to USD 894.87 million a year ago. Net income was USD 224.91 million compared to USD 201.75 million a year ago. Basic earnings per share from continuing operations was USD 1.53 compared to USD 1.38 a year ago. Diluted earnings per share from continuing operations was USD 1.53 compared to USD 1.37 a year ago.
For the six months, sales was USD 1,984.04 million compared to USD 1,798.89 million a year ago. Net income was USD 435.39 million compared to USD 405.36 million a year ago. Basic earnings per share from continuing operations was USD 2.97 compared to USD 2.78 a year ago. Diluted earnings per share from continuing operations was USD 2.95 compared to USD 2.76 a year ago.